Zhaidong Liu
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Bidirectional regulatory mechanisms and therapeutic prospects of tumor hypercoagulable state and immunosuppressive tumor microenvironment.
Journal: Oncology reviews
Published: April 23, 2026
Integrative single-cell analysis reveals TRIM31+ colorectal tumor cells orchestrating macrophage crosstalk within the cancer-immunity regulome.
Journal: Frontiers in immunology
Published: April 06, 2026
Efficacy and mechanisms of immune checkpoint inhibitors in late-stage EGFR-mutated non-small cell lung cancer following targeted therapy resistance.
Journal: Frontiers in immunology
Published: April 02, 2026
Optimal treatment strategies for EGFR mutant advanced lung adenocarcinoma patients with targeted therapy resistance and correlation analysis of PD-L1 expression with ICI efficacy.
Journal: Scientific reports
Published: February 15, 2026
An ultra-late maxillofacial cavity following multimodal treatment for adult head and neck rhabdomyosarcoma: a case report with a 16-year follow-up.
Journal: Frontiers in oncology
Published: December 11, 2025
Sanguinarine Antagonizes NSCLC Through PPARG-Mediated PI3K/AKT Suppression and Autophagic Apoptosis.
Sanguinarine Antagonizes NSCLC Through PPARG-Mediated PI3K/AKT Suppression and Autophagic Apoptosis.
Journal: Cell biochemistry and biophysics
Published: December 03, 2025
Combination of immune checkpoint inhibitors and anti-angiogenic agents: An emerging strategy for cancer therapy.
Journal: Critical reviews in oncology/hematology
Published: July 24, 2025
Integrative single-cell and spatial transcriptomics uncover ELK4-mediated mechanisms in NDUFAB1+ tumor cells driving gastric cancer progression, metabolic reprogramming, and immune evasion.
Journal: Frontiers in immunology
Published: March 10, 2025
Therapeutic Targets for Gastric Cancer: Mendelian Randomization and Colocalization Analysis.
Journal: Biological procedures online
Published: December 17, 2024
Current knowledge and potential intervention of hexosamine biosynthesis pathway in lung cancer.
Journal: World journal of surgical oncology
Published: July 12, 2023
Si Jun Zi decoction inhibits the growth of lung cancer by reducing the expression of PD-L1 through TLR4/MyD88/NF-κB pathway.
Journal: Journal of ethnopharmacology
Published: April 10, 2023
Showing 1-12 of 12
Last Updated: 09/26/2026